IMJUDO 300MG/15ML INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV)

MRP: ₹417522.64

ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV): Imjudo 300MG/15ML Injection, 1 vial, salt tremelimumab 300mg/15ml. Its MRP stays at Rs 417,522.64 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 318,112.49. Group: CTLA-4 inhibitor (immunotherapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: IV infusion in hospital only; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.